1Schindler R;Krautzig S;Lufft V.Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in vitro dialysis with whole blood,1996.
2Evans RC;Holmes CJ.In vitro study of the transfer of cytokine-inducing substances across-selected high-flux hemodialysis membranes[J],1991.
3Laude-Sharp M;CaroffM;Simard L.Indnction of IL-1 during hemodialysis:transmembrane passage of intact endotoxins (LPS)[J],1990.
4Dinarello CA;Roubenoff RA.Mechenisms of loss of lean body mass in patients on chronic dialysis,1996.
5Cheng JW;Rivera NG.Infection and atherosclerosis:Focus on cytomegalovirus and Chlamydia pneumoniae[J],1998(12).
6Epstein SE;Zhou YF;Zhu J.Infection and atherosclerosis:Emerging mechanistic paradigms[J],1999.
7Klein E;Pass T;Harding GB.Microbial and endotoxin contamination in water and dialysate in the central United States[J],1990.
8Lonnemann G;Benme TC;Lenzner B.Pemcability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria[J],1992.
9Lonnemann G;Bingel M;Gloege K.Detection of endotoxinlike interleukin-1-inducing activity during in vitro dialysis[J],1988.
10Arvanitidou M;Spaia S;Katsinas C.Microbiological quality of water and dialysate in all haemodialysis centres of Greece,1998.
3Schwalbe S, Holzhauer M, Schaeffer J, et al. Bate 2-microglobuling associated amyloidosis; A vanishing complication of long-term hemodialysis [J].Kidney Int, 1997,52:1 077- 1 083.
4Mclntyre C, Harper I, Macdougall IC, et al. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol, 1997,48(6) :371 - 378.
5Matsuhashi N, Yoshioka T. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients. Nephron,2002,92(3) :601 - 604.
6Barany P, Divino Filho JC, Bergstrom J. High C - reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis, 1997,29(4) :565 - 572.
7Sehiffi H, Lang SM, Bergner A. Ultrapure dialysate reduces dose of recombinant human erythropoietin. Nephron, 1999,83(3): 278 - 279.
8国家药典委员会编.中华人民共和国药典[M]第2部[M].北京:化学工业出版社,2000.428.
9McIntyre C,Harper I,Macdougall IC,et al. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol, 1997,48 (6):371-374.
10Panichi V,Migliori M ,De Pietro S,et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif,2000,18(3) : 183-190.
3Schwalbe S, Holzhauer M, Schaeffer J, et al. Bate 2-microglobuling associated amyloidosis; A vanishing complication of long-term hemodialysis [J].Kidney Int, 1997,52:1 077- 1 083.
4Mclntyre C, Harper I, Macdougall IC, et al. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol, 1997,48(6) :371 - 378.
5Matsuhashi N, Yoshioka T. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients. Nephron,2002,92(3) :601 - 604.
6Barany P, Divino Filho JC, Bergstrom J. High C - reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis, 1997,29(4) :565 - 572.
7Sehiffi H, Lang SM, Bergner A. Ultrapure dialysate reduces dose of recombinant human erythropoietin. Nephron, 1999,83(3): 278 - 279.
8国家药典委员会编.中华人民共和国药典[M]第2部[M].北京:化学工业出版社,2000.428.
9McIntyre C,Harper I,Macdougall IC,et al. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol, 1997,48 (6):371-374.
10Panichi V,Migliori M ,De Pietro S,et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif,2000,18(3) : 183-190.
